Funder: American Cancer Society
Due Dates: October 29, 2024 | June 1, 2026 (anticipated)
Funding Amounts: Up to $215,000/year (Research Scholar Grant) or $430,000/year (Team Award) for up to 4 years, plus 10% indirect costs.
Summary: Supports research on mechanisms and prevention of leukemia in RUNX1 familial platelet disorder, with a focus on cancer interception and early intervention therapies.
Key Information: Applicants may only submit one proposal per cycle and must apply for either the Research Scholar Grant or Team Award, not both.